论文部分内容阅读
目的观察倍他乐克联合地高辛治疗房颤患者的临床疗效和安全性。方法 120例房颤患者随机分为2组,对照组60例患者单纯给予地高辛治疗,观察组60例患者同时给予地高辛和加用倍他乐克,观察2组患者治疗前后心功能、心率和生活质量变化等指标。结果观察组患者心功能改善较对照组明显,患者运动时心率减少,生活质量明显提高,两者的差异有统计学意义(P<0.05)。结论倍他乐克联合地高辛是控制快速房颤心室率安全有效的方案。
Objective To observe the clinical efficacy and safety of Betaloc combined with digoxin in the treatment of atrial fibrillation. Methods A total of 120 patients with atrial fibrillation were randomly divided into two groups. Sixty patients in the control group were given digoxin alone. Sixty patients in the observation group were given digoxin and Betaloc. The two groups were observed before and after treatment , Heart rate and quality of life indicators. Results The improvement of cardiac function in the observation group was more obvious than that in the control group. The heart rate was decreased and the quality of life was significantly improved in the exercise group. The difference was statistically significant (P <0.05). Conclusion Betaloc and digoxin are safe and effective in controlling ventricular rate in patients with rapid AF.